You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Johnson & Johnson Resumes European Rollout After Regulator Says Benefits Outweigh Blood Clot Risk

HeadlineApr 21, 2021

Johnson & Johnson is resuming its rollout in Europe after the EU drugs regulator said the vaccine may be linked to extremely rare blood clots but that its benefits far outweigh its risks. The European regulator said the vaccine should carry a warning. It will be up to individual EU countries to decide whether and how to distribute the J&J vaccine. On Friday, a panel for the Centers for Disease Control and Prevention will meet to make recommendations on its use in the U.S., which has been temporarily halted.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top